How many insider declarations has Nemec Sarah filed?

Nemec Sarah has filed 3 public insider declarations with SEC (Form 4).

What is Nemec Sarah's role?

Nemec Sarah's reported role is not specified by the regulator across the filings.

Which companies does Nemec Sarah report trades for?

Nemec Sarah reports trades for Bolt Biotherapeutics, Inc..

What is Nemec Sarah's declared buy vs sell volume?

Across the available history, declared buys total 2k€ and disposals 0.

← Executives ★ Sign in to follow

NS

Nemec Sarah

OFFICER

·SEC (Form 4)

Bolt Biotherapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

€2,275

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

T+90 hit rate

33%

T+90 mean return

-9.1%

Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the full record of transactions filed by Nemec Sarah. Insider active across 1 company, notably Bolt Biotherapeutics, Inc.. In total, 3 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €2k. History available since 16 December 2024. The latest transaction was disclosed on 5 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Nemec Sarah

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Bolt Biotherapeutics, Inc. (US)

Declarations3 total

▲

Nemec Sarah

Senior VP, Finance and PAOExecutives5 Dec 2025Bolt Biotherapeutics, Inc.

$57641SEC ↗

125 shares@ US$4.60721.7% of flowCommon StockSEC:0001193125-26-037690:0

Canonical exit: 5 Mar 2026 (T+90)

▲

Nemec Sarah

Senior VP, Finance and PAOExecutives6 Jun 2025Bolt Biotherapeutics, Inc.

$68740SEC ↗

125 shares@ US$5.49233.7% of flowCommon StockSEC:0001193125-25-250334:0

Canonical exit: 4 Sept 2025 (T+90)

▲

Nemec Sarah

Senior VP, Finance and PAOExecutives16 Dec 2024Bolt Biotherapeutics, Inc.

$1,24143SEC ↗

2,500 shares@ US$0.4965100.0% of flowCommon StockSEC:0000950170-25-063846:0

Canonical exit: 16 Mar 2025 (T+90)

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

NS

Nemec Sarah

OFFICER

·SEC (Form 4)

Bolt Biotherapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

€2,275

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

T+90 hit rate

33%

T+90 mean return

-9.1%

Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the full record of transactions filed by Nemec Sarah. Insider active across 1 company, notably Bolt Biotherapeutics, Inc.. In total, 3 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €2k. History available since 16 December 2024. The latest transaction was disclosed on 5 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.